breast cancer and wbc count

Release time ：Dec-22,2024

The relationship between breast cancer and white blood cell (WBC) count is not a direct one. Breast cancer is a malignant tumor that originates in the epithelial cells of the mammary gland, whereas the WBC count is a blood test parameter that indicates the status of the immune system. Typically, the WBC count of individuals with breast cancer may be within the normal range, but it can increase in certain situations such as when there is an infection, inflammation, or other complications.

Upon further examination, it is observed that breast cancer patients receiving treatments like chemotherapy or radiotherapy may experience effects on their bone marrow, which can lead to a decrease in WBC count. This occurs because chemotherapeutic agents, while targeting cancer cells, can also harm hematopoietic stem cells within the bone marrow, thereby impacting the production of white blood cells. Moreover, some breast cancer patients may develop skeletal metastases, which can also impair bone marrow function and result in a reduced WBC count.

Regular monitoring of WBC count is crucial for breast cancer patients to promptly identify and address any potential issues. Should an abnormal WBC count be detected, it is imperative to seek medical attention promptly and to follow the prescribed treatment under a physician's guidance. Additionally, maintaining a healthy lifestyle, including a balanced diet, regular exercise, and avoiding exposure to harmful substances, can contribute to bolstering the body's immune system and reducing the risk of infections.